van der Walt M - Search Results

1

Draft Genome Sequences of Two Extensively Drug-Resistant Strains of Mycobacterium tuberculosis Belonging to the Euro-American S Lineage.

Malinga LA, Abeel T, Desjardins CA, Dlamini TC, Cassell G, Chapman SB, Birren BW, Earl AM, van der Walt M. Malinga LA, et al. Among authors: van der walt m. Genome Announc. 2016 Mar 3;4(2):e01771-15. doi: 10.1128/genomeA.01771-15. Genome Announc. 2016. PMID: 26941159 Free PMC article.

2

Propensity Score-Based Approaches to Confounding by Indication in Individual Patient Data Meta-Analysis: Non-Standardized Treatment for Multidrug Resistant Tuberculosis.

Fox GJ, Benedetti A, Mitnick CD, Pai M, Menzies D; Collaborative Group for Meta-Analysis of Individual Patient Data in MDR-TB. Fox GJ, et al. PLoS One. 2016 Mar 29;11(3):e0151724. doi: 10.1371/journal.pone.0151724. eCollection 2016. PLoS One. 2016. PMID: 27022741 Free PMC article.

3

Molecular analysis of genetic mutations among cross-resistant second-line injectable drugs reveals a new resistant mutation in Mycobacterium tuberculosis.

Malinga L, Brand J, Olorunju S, Stoltz A, van der Walt M. Malinga L, et al. Among authors: van der walt m. Diagn Microbiol Infect Dis. 2016 Aug;85(4):433-7. doi: 10.1016/j.diagmicrobio.2016.05.010. Epub 2016 May 20. Diagn Microbiol Infect Dis. 2016. PMID: 27298046 Free article.

4

Genomic analysis of globally diverse Mycobacterium tuberculosis strains provides insights into the emergence and spread of multidrug resistance.

Manson AL, Cohen KA, Abeel T, Desjardins CA, Armstrong DT, Barry CE 3rd, Brand J; TBResist Global Genome Consortium; Chapman SB, Cho SN, Gabrielian A, Gomez J, Jodals AM, Joloba M, Jureen P, Lee JS, Malinga L, Maiga M, Nordenberg D, Noroc E, Romancenco E, Salazar A, Ssengooba W, Velayati AA, Winglee K, Zalutskaya A, Via LE, Cassell GH, Dorman SE, Ellner J, Farnia P, Galagan JE, Rosenthal A, Crudu V, Homorodean D, Hsueh PR, Narayanan S, Pym AS, Skrahina A, Swaminathan S, Van der Walt M, Alland D, Bishai WR, Cohen T, Hoffner S, Birren BW, Earl AM. Manson AL, et al. Among authors: van der walt m. Nat Genet. 2017 Mar;49(3):395-402. doi: 10.1038/ng.3767. Epub 2017 Jan 16. Nat Genet. 2017. PMID: 28092681 Free PMC article.

5

Outcomes of multi-drug resistant tuberculosis (MDR-TB) among a cohort of South African patients with high HIV prevalence.

Farley JE, Ram M, Pan W, Waldman S, Cassell GH, Chaisson RE, Weyer K, Lancaster J, Van der Walt M. Farley JE, et al. Among authors: van der walt m. PLoS One. 2011;6(7):e20436. doi: 10.1371/journal.pone.0020436. Epub 2011 Jul 22. PLoS One. 2011. PMID: 21799728 Free PMC article. Clinical Trial.

6

Early culture conversion and cure for extensively drug-resistant tuberculosis is possible with appropriate treatment: lessons learnt from a case study in South Africa.

Shean K, Siwendu S, van der Walt M. Shean K, et al. Among authors: van der walt m. Int J Infect Dis. 2015 Nov;40:92-4. doi: 10.1016/j.ijid.2015.09.020. Epub 2015 Oct 13. Int J Infect Dis. 2015. PMID: 26439970 Free article.

7

Early treatment outcomes and HIV status of patients with extensively drug-resistant tuberculosis in South Africa: a retrospective cohort study.

Dheda K, Shean K, Zumla A, Badri M, Streicher EM, Page-Shipp L, Willcox P, John MA, Reubenson G, Govindasamy D, Wong M, Padanilam X, Dziwiecki A, van Helden PD, Siwendu S, Jarand J, Menezes CN, Burns A, Victor T, Warren R, Grobusch MP, van der Walt M, Kvasnovsky C. Dheda K, et al. Among authors: van der walt m, van helden pd. Lancet. 2010 May 22;375(9728):1798-807. doi: 10.1016/S0140-6736(10)60492-8. Lancet. 2010. PMID: 20488525 Free article.

8

Extensively drug-resistant tuberculosis (XDR-TB) among health care workers in South Africa.

Jarand J, Shean K, O'Donnell M, Loveday M, Kvasnovsky C, Van der Walt M, Adams S, Willcox P, O'Grady J, Zumla A, Dheda K. Jarand J, et al. Among authors: van der walt m. Trop Med Int Health. 2010 Oct;15(10):1179-84. doi: 10.1111/j.1365-3156.2010.02590.x. Trop Med Int Health. 2010. PMID: 20831672 Free article.

9

Extensive drug resistance acquired during treatment of multidrug-resistant tuberculosis.

Cegielski JP, Dalton T, Yagui M, Wattanaamornkiet W, Volchenkov GV, Via LE, Van Der Walt M, Tupasi T, Smith SE, Odendaal R, Leimane V, Kvasnovsky C, Kuznetsova T, Kurbatova E, Kummik T, Kuksa L, Kliiman K, Kiryanova EV, Kim H, Kim CK, Kazennyy BY, Jou R, Huang WL, Ershova J, Erokhin VV, Diem L, Contreras C, Cho SN, Chernousova LN, Chen MP, Caoili JC, Bayona J, Akksilp S; Global Preserving Effective TB Treatment Study (PETTS) Investigators. Cegielski JP, et al. Among authors: van der walt m. Clin Infect Dis. 2014 Oct 15;59(8):1049-63. doi: 10.1093/cid/ciu572. Epub 2014 Jul 23. Clin Infect Dis. 2014. PMID: 25057101 Free PMC article.

10

Tuberculosis Case Fatality and Other Causes of Death among Multidrug-Resistant Tuberculosis Patients in a High HIV Prevalence Setting, 2000-2008, South Africa.

van der Walt M, Lancaster J, Shean K. van der Walt M, et al. PLoS One. 2016 Mar 7;11(3):e0144249. doi: 10.1371/journal.pone.0144249. eCollection 2016. PLoS One. 2016. PMID: 26950554 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

130 results

Search Page

Filters